Sunshine Biopharma Inc. short interest in 2022
In 2022, Sunshine Biopharma Inc.'s disclosed short interest ran from 6.25% of shares outstanding on 15 Mar 2022 to 1.69% on 30 Dec 2022, a change of -4.56 percentage points. The year's high was 11.65% on 13 May 2022 and its low 1.69% on 30 Dec 2022, averaging 4.48% across 11 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.74 days on 15 Dec 2022. Full history: Sunshine Biopharma Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 6.25% (15 Mar 2022)
- End of year
- 1.69% (30 Dec 2022)
- Change
- -4.56 pp
- High
- 11.65% (13 May 2022)
- Low
- 1.69% (30 Dec 2022)
- Average
- 4.48%
- Highest days to cover
- 3.74 (15 Dec 2022)
- SEC filings marked
- 4
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Mar 2022 | 6.25% | 1.00 | |
| 29 Apr 2022 | 8.81% | 1.00 | 10-K filed |
| 13 May 2022 | 11.65% | 1.00 | 10-Q filed |
| 29 Jul 2022 | 6.89% | 1.00 | |
| 15 Aug 2022 | 3.13% | 1.00 | 10-Q filed |
| 31 Aug 2022 | 2.10% | 1.19 | |
| 31 Oct 2022 | 2.84% | 1.00 | |
| 15 Nov 2022 | 1.86% | 1.78 | 10-Q filed |
| 30 Nov 2022 | 2.12% | 1.00 | |
| 15 Dec 2022 | 1.99% | 3.74 | |
| 30 Dec 2022 | 1.69% | 2.85 |
See also: Sunshine Biopharma Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.